Connect Sign In
LabMind podcasts
|
April 15, 2024 |
Jump Into Lab Week With Podcasts, Articles, and Lectures That Highlight the Value of Laboratories Join ARUP in kickstarting Lab Week with a curated selection of podcasts, articles, and lectures that emphasize the important role medical lab professionals play in improving and saving patient lives. |
Come to booth #1038 to see ARUP’s showcase of various suites of neurology laboratory testing and meet ARUP medical directors and experts ready to answer questions. |
April 8, 2024 |
ARUP to Showcase Neurology Laboratory Testing Menu at Upcoming American Academy of Neurology Meeting ARUP medical directors and experts will be present to discuss the latest developments in neurology laboratory testing at the upcoming American Academy of Neurology (AAN) Annual Meeting. |
Dan Albertson, MD, will serve as president of the University Business Unit. |
April 1, 2024 |
New ARUP University Business Unit Focuses on Patients and Services at University of Utah Health Dan Albertson, MD, will serve as president of the new University Business Unit and become a member of ARUP’s executive committee. Albertson said service to patients and colleagues will be his focus. |
Michael Pyne, MS, a scientist in ARUP’s R&D Infectious Disease group, performs next generation sequencing (NGS) testing for HIV drug resistance, which is a lab-developed test. |
March 21, 2024 | The FDA’s proposed rule to regulate lab-developed tests will force labs to halt essential testing, harming children and patients with cancer and rare diseases, says ARUP’s Jonathan Genzen, MD, PhD. |
An expert in TAR DNA-binding protein of 43 kDa (TDP-43), neuropathologist Qinwen Mao, MD, PhD, subspecialty director of Neuropathology at ARUP, is working to identify biomarkers that predict the presence of TDP-43 pathology to contribute to the diagnosis of frontotemporal lobar degeneration (FTLD) and Alzheimer’s disease. |
March 20, 2024 |
FDA-Approved Tests and Treatment Offer Hope in the Fight Against Alzheimer’s Disease ARUP’s new test, Alzheimer’s Disease Markers, CSF, will pave the way for more assays that help detect the disease soon enough to try therapy to slow its progression. |
The results of the annual client satisfaction survey show clients’ impressions improved in 2023, building on already positive 2022 results. |
March 15, 2024 |
ARUP’s Customer Service Continues to Rank High in Annual Client Survey Results Of the ARUP clients who participated in the 2023 client satisfaction survey, 93% had a favorable impression of the company, up from 91% in 2022. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine We accelerate groundbreaking diagnostic and prognostic technologies to drive life-changing innovation. Our large, single-site operation and renowned quality framework, combined with our extensive expertise, provide an ideal incubator to advance custom projects for innovative partners. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat